Members |
targetComponentId |
Amniotomy at delivery |
Amniotomy at delivery (procedure) |
Amniotomy by nurse |
Artificial rupture of membranes (procedure) |
Amniotomy by nurse |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy by nurse |
Amniotomy at delivery (procedure) |
Amniotomy to induce labor |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Amniotomy at delivery (procedure) |
Amniotomy to induce labor |
Surgical induction of labour |
Amniotomy to induce labor |
Artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Sweeping of membrane |
Amoeba species |
Amoeba |
Amoebiasis |
Infection due to Entamoeba histolytica |
Amoebiasis |
Amebic dysentery (disorder) |
Amoebiasis |
Amebic infection |
Amoebiasis affecting skin |
Amebic ulcer of skin (disorder) |
Amoebiasis affecting skin |
Amoebiasis of skin |
Amoxicillin + clavulanate potassium adverse reaction |
Adverse reaction to amoxicillin and/or clavulanic acid |
Amoxicillin and clavulanate |
Product containing amoxicillin and clavulanic acid (medicinal product) |
amphétamine |
Amfetamine |
Amphetamine and cocaine |
Product containing amfetamine (medicinal product) |
Amphetamine and cocaine |
Product containing cocaine (medicinal product) |
Amphetamine or psychostimulant |
Psychostimulant |
Amphetamine or psychostimulant |
Product containing amfetamine (medicinal product) |
Amphetamine overdose |
Amfetamine and/or amfetamine derivative overdose (disorder) |
Amphetamine poisoning of undetermined intent |
Poisoning caused by amfetamine and/or amfetamine derivative |
Amphotericin (lipid formulation) 50mg powder for infusion solution vial |
Amphotericin B liposome 50 mg powder for solution for injection vial |
amphotéricine 100 mg, fiole de poudre pour perfusion |
Amphotericin B only product in parenteral dose form |
Amphotericin 100mg/mL s/f suspension |
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Amphotericin 5mg/mL conventional release suspension for injection 20mL vial |
Amphotericin B only product in parenteral dose form |
amphotéricine 5 mg/mL, flacon de 20 mL de concentré pour perfusion |
Amphotericin B only product in parenteral dose form |
Ampicillin + flucloxacillin adverse reaction |
Adverse reaction to ampicillin and/or flucloxacillin (disorder) |
Ampicillin and cloxacillin adverse reaction |
Adverse reaction to ampicillin and/or cloxacillin |
Ampicillin and sulbactam |
Product containing ampicillin and sulbactam (medicinal product) |
Ampicillin with sulbactam |
Ampicillin (substance) |
Ampicillin with sulbactam |
Sulbactam |
jambe amputée |
Amputated lower limb (finding) |
Amputated structure, traumatic, delayed |
Amputated structure, delayed |
Amputation of arm through wrist |
Disarticulation at wrist |
Amputation of arm through wrist |
Amputation of arm through wrist (procedure) |
Amputation of cervix |
Cervix excision |
Amputation of cervix |
Cervix excision |
Amputation of cervix |
Amputation of cervix (procedure) |
Amputation of cervix |
Amputation of cervix (procedure) |
Amputation of foot: [Hey] or [NOS] |
Amputation of the foot |
Amputation of leg |
Amputation of lower limb (procedure) |
Amputation of leg |
Amputation of leg through tibia and fibula |
Amputation of lower limb (& disarticulation) |
Amputation of lower limb (procedure) |
Amputation of lower limb (& disarticulation) |
Amputation of lower limb (procedure) |
Amputation of lower limb (& disarticulation) |
Amputation of leg through tibia and fibula |
Amputation of lower limb (& disarticulation) |
Disarticulation of hip |
Amputation of toe |
Amputation of toe (procedure) |
Amputation of toe |
Disarticulation of toe |
Amputation of toe |
Amputation of toe (procedure) |
Amputation of toe NOS |
Amputation of toe (procedure) |
Amputation of toe NOS |
Disarticulation of toe |
amputation du bras |
Above elbow amputation |
Amputation of upper arm |
Amputation of arm through shoulder |
amputation du bras |
Amputation of arm through shoulder |
Amputation of upper arm |
Above elbow amputation |
Amputation of upper limb (& disarticulation) |
Amputation of arm through shoulder |
Amputation of upper limb (& disarticulation) |
Amputation of upper limb (procedure) |
Amputation through knee |
Through knee amputation |
Amsinckia species |
Amsinckia |
Amycolatopsis species |
Amycolatopsis |
Amylase + lipase + protease 58500unt/18000unt/58500unt |
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Product containing amylase (medicinal product) |
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Protease-containing product |
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
Product containing triacylglycerol lipase (medicinal product) |
Amyloid polyneuropathy type I |
Familial amyloid polyneuropathy, Jewish type |
Amyloid polyneuropathy type I |
Amyloid polyneuropathy type I (disorder) |
Amyloid pterygium |
Pterygium |
Amyloidosis, type I |
Amyloid polyneuropathy type I (disorder) |
Amyloidosis, type I |
Familial amyloid polyneuropathy, Jewish type |
Anaemia &/or blood screening |
Anemia screening |
Anaemia &/or blood screening |
Anemia screening |
Anaemia NOS: [other deficiency] or [megaloblastic] |
Megaloblastic anemia |
Anaemia NOS: [other deficiency] or [megaloblastic] |
Deficiency anemias |
Anaemia due to chronic blood loss: [iron deficiency] or [normocytic] |
Acute posthemorrhagic anemia |
Anaemia due to chronic blood loss: [iron deficiency] or [normocytic] |
Normocytic anemia due to chronic blood loss |
Anaemia due to chronic blood loss: [iron deficiency] or [normocytic] |
Anemia due to chronic blood loss (disorder) |
Anaemia/blood screening NOS |
Anemia screening |
Anaemia/blood screening NOS |
Occult blood screening |
Anaemia: [acquired aplastic NOS] or [acquired pure red cell aplasia] or [red cell hypoplasia] or [secondary red cell aplasia or hypoplasia NEC] |
Pure red cell aplasia |
Anaemia: [acquired aplastic NOS] or [acquired pure red cell aplasia] or [red cell hypoplasia] or [secondary red cell aplasia or hypoplasia NEC] |
Acquired aplastic anemia |
Anaemia: [acquired aplastic NOS] or [acquired pure red cell aplasia] or [red cell hypoplasia] or [secondary red cell aplasia or hypoplasia NEC] |
Acquired red cell aplasia |
Anaemia: [acquired aplastic] or [normocytic due to aplasia] |
Normocytic anemia due to aplasia |
Anaemia: [aplastic and other] or [aplastic] or [hypoblastic] |
Anemia |
Anaemia: [aplastic and other] or [aplastic] or [hypoblastic] |
Aplastic anaemia |
Anaemia: [aplastic and other] or [aplastic] or [hypoblastic] |
Aplastic anaemia |
Anaemia: [aplastic and other] or [aplastic] or [hypoblastic] |
Anemia |
Anaemia: [aplastic due to drugs] or [hypoplastic due to drug or chemical substance] |
Aplastic anemia due to drugs |
Anaemia: [congenital hypoplastic] or [constitutional aplastic without mention of malformation] |
Constitutional aplastic anemia |
Anaemia: [deficiency excluding iron] or [megaloblastic] |
Megaloblastic anemia |
Anaemia: [deficiency excluding iron] or [megaloblastic] |
Deficiency anaemias, excluding iron |
Anaemia: [deficiency excluding iron] or [megaloblastic] |
Deficiency anaemias, excluding iron |
Anaemia: [deficiency excluding iron] or [megaloblastic] |
Megaloblastic anemia |
Anaemia: [folate-deficiency or megaloblastic due to dietary causes] or [goat's milk] |
Folate deficiency anaemia due to dietary causes |
Anaemia: [folate-deficiency or megaloblastic due to dietary causes] or [goat's milk] |
Megaloblastic anaemia due to dietary causes |
Anaemia: [folate-deficiency or megaloblastic due to dietary causes] or [goat's milk] |
Goats' milk anemia |
Anaemia: [megaloblastic] or [other deficiency] |
Megaloblastic anemia |
Anaemia: [other specified] or [Von Jaksch's] |
von Jaksch's anemia |
Anaemia: [unspecified] or [secondary NOS] or [normocytic or macrocytic of unspecified cause] |
Anemia |